Cargando…
Using Genetics To Dissect SARS-CoV-2 Infection
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689311/ https://www.ncbi.nlm.nih.gov/pubmed/33309104 http://dx.doi.org/10.1016/j.tig.2020.11.007 |
_version_ | 1783613839223291904 |
---|---|
author | Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard |
author_facet | Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard |
author_sort | Brest, Patrick |
collection | PubMed |
description | To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19. |
format | Online Article Text |
id | pubmed-7689311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76893112020-11-27 Using Genetics To Dissect SARS-CoV-2 Infection Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard Trends Genet Spotlight To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19. Elsevier Ltd. 2021-03 2020-11-26 /pmc/articles/PMC7689311/ /pubmed/33309104 http://dx.doi.org/10.1016/j.tig.2020.11.007 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Spotlight Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard Using Genetics To Dissect SARS-CoV-2 Infection |
title | Using Genetics To Dissect SARS-CoV-2 Infection |
title_full | Using Genetics To Dissect SARS-CoV-2 Infection |
title_fullStr | Using Genetics To Dissect SARS-CoV-2 Infection |
title_full_unstemmed | Using Genetics To Dissect SARS-CoV-2 Infection |
title_short | Using Genetics To Dissect SARS-CoV-2 Infection |
title_sort | using genetics to dissect sars-cov-2 infection |
topic | Spotlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689311/ https://www.ncbi.nlm.nih.gov/pubmed/33309104 http://dx.doi.org/10.1016/j.tig.2020.11.007 |
work_keys_str_mv | AT brestpatrick usinggeneticstodissectsarscov2infection AT mograbibaharia usinggeneticstodissectsarscov2infection AT hofmanpaul usinggeneticstodissectsarscov2infection AT milanogerard usinggeneticstodissectsarscov2infection |